GetTopicDetailResponse(id=3ea83260c5, topicName=Bcl-2抑制劑APG-2575, introduction=Bcl-2抑制劑APG-2575, content=null, image=null, comments=4, allHits=1139, url=https://h5.medsci.cn/topic?id=3260, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102363, tagList=[TagDto(tagId=102363, tagName=Bcl-2抑制劑APG-2575)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1773144, encodeId=c6cc1e73144e4, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制劑APG-2575#</a>, objectTitle=FDA授予Bcl-2抑制劑APG-2575孤兒藥資格，用于治療慢性淋巴細(xì)胞性白血病, objectType=article, longId=200404, objectId=d860200404a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d860200404a6, replyNumber=0, likeNumber=77, createdTime=2020-12-17, rootId=0, userName=minzju5065, userId=fa1038497429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d860200404a6, moduleTitle=FDA授予Bcl-2抑制劑APG-2575孤兒藥資格，用于治療慢性淋巴細(xì)胞性白血病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d860200404a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773145, encodeId=80cc1e73145ea, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制劑APG-2575#</a>, objectTitle=美國(guó)FDA授予Bcl-2抑制劑APG-2575第五個(gè)孤兒藥稱(chēng)號(hào)，用以治療濾泡性淋巴瘤（FL）, objectType=article, longId=206517, objectId=375420651efe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=375420651efe, replyNumber=0, likeNumber=75, createdTime=2021-11-27, rootId=0, userName=minzju5065, userId=fa1038497429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=375420651efe, moduleTitle=美國(guó)FDA授予Bcl-2抑制劑APG-2575第五個(gè)孤兒藥稱(chēng)號(hào)，用以治療濾泡性淋巴瘤（FL）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=375420651efe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773143, encodeId=05bc1e7314325, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制劑APG-2575#</a>, objectTitle=亞盛醫(yī)藥獲得FDA授予第二個(gè)孤兒藥稱(chēng)號(hào)：Bcl-2抑制劑APG-2575治療華氏巨球蛋白血癥, objectType=article, longId=197635, objectId=8f5319e6350c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5319e6350c, replyNumber=0, likeNumber=84, createdTime=2021-01-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5319e6350c, moduleTitle=亞盛醫(yī)藥獲得FDA授予第二個(gè)孤兒藥稱(chēng)號(hào)：Bcl-2抑制劑APG-2575治療華氏巨球蛋白血癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8f5319e6350c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773142, encodeId=46af1e7314200, content=<a href='/topic/show?id=3ea83260c5' target=_blank style='color:#2F92EE;'>#Bcl-2抑制劑APG-2575#</a>, objectTitle=亞盛藥業(yè)的Bcl-2抑制劑APG-2575用于慢性淋巴細(xì)胞白血病或小淋巴細(xì)胞淋巴瘤的Ib/II期臨床，獲得NMPA的批準(zhǔn), objectType=article, longId=191730, objectId=1f9c191e301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f9c191e301a, replyNumber=0, likeNumber=98, createdTime=2020-08-20, rootId=0, userName=minzju5065, userId=fa1038497429, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f9c191e301a, moduleTitle=亞盛藥業(yè)的Bcl-2抑制劑APG-2575用于慢性淋巴細(xì)胞白血病或小淋巴細(xì)胞淋巴瘤的Ib/II期臨床，獲得NMPA的批準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1f9c191e301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
